Fax: +44 1865-289287
1097-0215/asset/olbannerleft.jpg?v=1&s=45719cd7de57873027993264fcc568b335a8cd56)
1097-0215/asset/olbannerright.jpg?v=1&s=5e0fba63c1309b3036eb9215a0e1e83dd02efd19)
Epidemiology
You have full text access to this OnlineOpen article
Factors associated with incident and fatal pancreatic cancer in a cohort of middle-aged women
Article first published online: 3 DEC 2008
DOI: 10.1002/ijc.24196
Copyright © 2008 Wiley-Liss, Inc.
Additional Information
How to Cite
Stevens, R. J., Roddam, A. W., Spencer, E. A., Pirie, K. L., Reeves, G. K., Green, J., Beral, V. and on behalf of the Million Women Study Collaborators (2009), Factors associated with incident and fatal pancreatic cancer in a cohort of middle-aged women. Int. J. Cancer, 124: 2400–2405. doi: 10.1002/ijc.24196
- †
Fax: +44 1865-289287
- ‡
Million Women Study Collaborators.Steering Committee: Joan Austoker, Cancer Research UK Primary Care Education Research Group, Oxford, United Kingdom; Emily Banks, National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australia; Valerie Beral, Gillian Reeves, Cancer Epidemiology Unit, Oxford, United Kingdom; Judith Church (lay member), Ruth English, Oxford Radcliffe Hospital NHS Trust, The Churchill Hospital, Oxford, United Kingdom; Julietta Patnick, NHS Cancer Screening Programmes, Sheffield, United Kingdom; Richard Peto, Clinical Trial Service Unit and Epidemiological Studies Unit, Oxford, United Kingdom; Martin Vessey, St Cross College, Oxford, United Kingdom; Matthew Wallis, Addenbrokes Hospital, Cambridge, United Kingdom.Million Women Study Coordinating Centre Staff: Simon Abbott, Krys Baker, Angela Balkwill, Sue Bellenger, Valerie Beral, Judith Black, Anna Brown, Diana Bull, Delphine Casabonne, Barbara Crossley, Dave Ewart, Sarah Ewart, Lee Fletcher, Toral Gathani, Laura Gerrard, Adrian Goodill, Jane Green, Winifred Gray, Joy Hooley, Sau Wan Kan, Carol Keene, Nicky Langston, Bette Liu, Sarit Nehushtan, Lynn Pank, Kirstin Pirie, Gillian Reeves, Andrew Roddam, Emma Sherman, Moya Simmonds, Elizabeth Spencer, Richard Stevens, Helena Strange, Sian Sweetland, Aliki Taylor, Alison Timadjer, Sarah Tipper, Joanna Watson, Stephen Williams, Cancer Epidemiology Unit, Oxford, United Kingdom.Collaborating UK NHS Breast Screening Centres: E.D.C. Anderson, Scottish Breast Screening Programme, Edinburgh, United Kingdom; G. Athey, Breast Screening Service, West Cumberland Hospital, Cumbria, United Kingdom; R. Bannon, Breast Screening Unit, West Suffolk Hospital, Bury St Edmunds, United Kingdom; S. Barker, Cambridge Breast Unit, Addenbrookes Hospital, Cambridge, United Kingdom; N.K. Barrett, West of London Breast Screening Service, Charing Cross Hospital, London, United Kingdom; C.H. Beattie, Breast Screening Unit, Women's Hospital, Liverpool, United Kingdom; M.G. Bell, West Berkshire Breast Screening Service, Reading, United Kingdom; R. Bhatt, Breast Screening Service, City Hospital NHS Trust, Birmingham, United Kingdom; S. Bradley, Breast Screening Service, Birmingham Women's Hospital, Birmingham, United Kingdom; D. Brown, East of Scotland Breast Screening Centre, Ninewells Hospital, Dundee, United Kingdom; K.L. Cheung, The Breast Institute, City Hospital, Nottingham, United Kingdom; J. Cooke, Jarvis Breast Screening Diagnostic and Training Centre, Surrey, United Kingdom; E.J. Cornford, Welcome Centre Breast Screening Unit, The Kings Mill Centre For Health Care Services, Sutton-in Ashfield, United Kingdom; M. Creagh-Barry, The Dorset Breast Screening Unit, Dorset, United Kingdom; M. Crotch-Harvey, Victoria Breast Centre Macclesfield District General Hospital, Cheshire, United Kingdom; H. Daintith, Leicestershire Breast Screening Service, Glenfield Hospital NHS Trust, Leicester, United Kingdom; C. Dale, Breast Screening Service, Princess of Wales Community Hospital, Bromsgrove, United Kingdom; R. Davies, East Devon Breast Screening Unit, Royal Devon and Exeter Hospital, Exeter, United Kingdom; H. Deans, North East Scotland Breast Screening Centre, Aberdeen, United Kingdom; A. Duncan and R. Ramachandra, Breast Screening Unit, Coventry and Warwick Hospital, Coventry, United Kingdom; R. English, The Breast Care Unit, Oxford Radcliffe Hospital NHS Trust, The Churchill Hospital, Oxford, United Kingdom; A. Fielding, Shropshire Health Authorities, Shrewsbury, United Kingdom; S. Gelep, Breast Screening Unit, Barnsley District General Hospital, Barnsley, United Kingdom; D. Green, Wirral Breast Sceening Unit, Clatterbridge Hospital, Bebington, United Kingdom; P.E. Gordon, Patricia Massey Breast Screening Unit, Queen Alexandra Hospital, Hants, United Kingdom; M. Hall, Windsor Breast Diagnostic Centre, King Edward V11 Hospital, Berks, United Kingdom; A. Havard, Breast Screening Unit, Milton Keynes General Hospital NHS Trust, Milton Keynes, United Kingdom; R.N. Harland South Lancashire Breast Screening Unit, Thomas Linacre Out, Wigan, United Kingdom; P.J. Hendry, North of Scotland Breast Screening Service, Raigmore Hospital, Inverness, United Kingdom; F. Holly Archer, Breast Care Unit, James Paget Hospital, Great Yarmouth, United Kingdom; J.E. Houghton, Chester District Breast Screening Unit, Chester, United Kingdom; G. Hunnam, Breast Care Unit, Queen Elizabeth Hospital, King's Lynn, United Kingdom; C. Ingram, Sheffield Health, Sheffield, United Kingdom; P.A. Jones, Primrose Breast Care Unit, Derriford Hospital, Plymouth, United Kingdom; B. Kaye, Breast Screening Administration, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom; E. Kutt, Avon Breast Screening, Central Health Clinic, Bristol, United Kingdom; J. Lavelle, North Lancashire and South Cumbria Breast Screening Service, Royal Lancaster Infirmary, Lancaster, United Kingdom; E. Lindsay, South West Scotland Breast Screening Service, Ayrshire Central Hospital, Irvine, United Kingdom; S. Lowe, Kent Breast Screening Service, Kent and Canterbury Hospital, Kent, United Kingdom; P. Loynes, South Staffordshire Breast Screening Service, Cannock Chase Hospital, Staffs, United Kingdom; L.G. Lunt, Breast Screening & Assessment Unit, Queen Elizabeth Hospital, Gateshead, United Kingdom; I.D. Lyburn, Gloucestershire Breast Screening Service, Glos, United Kingdom; A. Murphy, North Yorkshire Breast Screening Services, Screening Office York District Hospital, York, United Kingdom; G. O'Sullivan, Winchester Breast Screening Unit, Royal Hampshire County Hospital, Hants, United Kingdom; R. Pitcher, Mammography Unit, Royal Cornwall Hospital, Cornwall, United Kingdom; C. Record, Aylesbury Breast Screening Service, Stoke Mandeville Hospital NHS Trust, Bucks, United Kingdom; C. Record, Wycombe General Hospital, Bucks, United Kingdom; N. Rothnie, South Essex Breast Screening Service, Nightingale Centre Southend Hospital, Essex, United Kingdom; G. Rubin, Breast Assessment Centre, Royal Sussex County Hospital, Brighton, United Kingdom; J. Scally, Breast Screening Unit, Leighton Hospital, Cheshire, United Kingdom; A. Sever, The Peggy Wood Breast Care Centre, Maidstone Hospital, Kent, United Kingdom; A. Sheridan, Breast Screening Unit, Warrington Hospital, Cheshire, United Kingdom; O. Strukowska, The West Sussex Breast Screening Service, Worthing Hospital, West Sussex, United Kingdom; S. Taylor, Wiltshire Breast Screening Unit, The Great Western Hospital, Swindon, United Kingdom; W. Teh, North of London Breast Screening Service, Edgware Community Hospital, Edgware, United Kingdom; W.D. Thompson, Breast Screening Service, Cleveland, United Kingdom; R. Toye, Breast Screening Unit, Medway Hospital, Gillingham, United Kingdom; A. Turnbull, Breast Screening Unit, Derby City General Hospital, Derby, United Kingdom; S. Varkey, Rotherham Breast Screening and Assessment Unit, Rotherham General Hospital, Rotherham, United Kingdom; D.A. Ward, Doncaster Breast Screening Centre, Cameo Centre, Doncaster, United Kingdom; W.P. Whitear, Breast Sceening Centre, Ipswich Hospital NHS Trust, Ipswich, United Kingdom; R. Whitney, Chelmsford and Colchester Breast Screening Service, Essex County Hospital, Essex, United Kingdom; M. Wilson, Greater Manchester Breast Screening Service, Withington Hospital, Manchester, United Kingdom; S. Wilson, Somerset Breast Screening, Breast Care Centre, Musgrove Park Hospital, Somerset, United Kingdom; D. Wright, Breast Screening Service, Luton and Dunstable Hospital, Luton, United Kingdom.
Publication History
- Issue published online: 16 MAR 2009
- Article first published online: 3 DEC 2008
- Accepted manuscript online: 3 DEC 2008 12:00AM EST
- Manuscript Accepted: 12 NOV 2008
- Manuscript Received: 11 JUL 2008
Funded by
- Cancer Research UK
- Medical Research Council
- UK National Health Service Breast Screening Programme
References
- 1Office for National Statistics. Mortality statistics: cause. Review of the Registrar General on deaths by cause, sex and age, in England and Wales, 2005.
- 2IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.Tobacco smoke and involuntary smoking IARC monographs on the evaluation of carcinogenic risks to humans, vol. 83. International Agency for Research on Cancer: Lyon, France, 2004.
- 3,,,. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg 2008; 393: 535–45.
- 4,. Diabetes mellitus as a risk factor for pancreatic cancer: a meta-analysis. J Am Med Assoc 1995; 273: 1605–9.
- 5,,,,. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005; 92: 2076–83.
- 6,,,. Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 2000; 11: 915–23.
- 7,,,,,. Physical activity, obesity, height, and the risk of pancreatic cancer. J Am Med Assoc 2001; 286: 921–9.
- 8,,,,. Pancreatic cancer and factors associated with the insulin resistance syndrome in the Korean cancer prevention study. Cancer Epidemiol Biomarkers Prev 2008; 17: 359–64.
- 9,,,. Lack of association of physical activity and obesity with incident pancreatic cancer in elderly women. Cancer Epidemiol Biomarkers Prev 2005; 14: 1571–3.
- 10,,,,,,. Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan—the JPHC study. Cancer Causes Control 2007; 18: 603–12.
- 11
- 12. Model checking in the Cox regression. In: ChatfieldC,TannerM,ZidekJ, eds.Modelling survival data in medical researched, Vol. 2. USA: Chapman & Hall/CRC Press, 2003: 146–8.
- 13,,. Health and deprivation: inequality and the North. London: Croom Helm, 1988.
- 14,,. Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med 1991; 10: 1025–35.
- 15,,,,,,. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. J Am Med Assoc 2005; 294: 2872–8.
- 16,,,,,,,. A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med 1996; 156: 2255–60.
- 17,,. Cancer incidence in female smokers: a 26-year follow-up. Int J Cancer 1997; 73: 625–8.
- 18,,,,,,,. Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP diet and health cohort. Am J Epidemiol 2008; 167: 586–97.
- 19,,,,. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569–78.
- 20,,,. Regression calibration in failure time regression. Biometrics 1997; 53: 131–45.
- 21World Congress of Gastroenterology Symposium Participants. Diabetes and pancreatic cancer: the egg or the hen? Abstracts of the symposium. A meeting of the World Congress of Gastroenterology. October 5, 1994, Los Angeles, CA. Int J Pancreatol 1994; 16: 81–98.
- 22,,. Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis. Br J Cancer 2007; 96: 507–9.
- 23,,,,. A prospective study of medical conditions, anthropometry, physical activity, and pancreatic cancer in male smokers (Finland). Cancer Causes Control 2002; 13: 417–26.
- 24,,,,,,,,,. Obesity, physical activity and the risk of pancreatic cancer in a large Japanese cohort. Int J Cancer 2007; 120: 2665–71.
- 25,. Alcohol and cancer. Lancet Oncol 2006; 7: 149–56.
- 26,,,,,,,,,,,. Comparison of various characteristics of women who do and do not attend for breast cancer screening. Breast Cancer Res 2002; 4: R1.
- 27,,,. Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr 2002; 5: 561–5.
- 28
- 29,,,,,,,,,,,, et al. Prevalence of chronic diseases in older Italians: comparing self-reported and clinical diagnoses. Int J Epidemiol 1997; 26: 995–1002.
- 30,,,,. Reliability and changes in validity of self-reported cardiovascular disease risk factors using dual response: the behavioral risk factor survey. J Clin Epidemiol 1996; 49: 511–17.
- 31,,,,,. Reliability and validity of interview data on chronic disease. The Mini-Finland Health Survey. J Clin Epidemiol 1993; 46: 181–91.
- 32,,,,,. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health 1994; 84: 1086–93.